Compared with benign meningiomas, aggressive meningiomas always exhibited immunological defects such as a decrease in CD4+ and CD8+ T lymphocytes, an increase in FOXP3+ Treg and PD-L1 (programmed death-ligand 1) levels26, 27, 28, 29, 30. The gene discussed is FOXP3; the disease is meningioma.